Back to Ophthalmology

OUR EXPERTISE AND SERVICES AVAILABLE IN

nAMD

Neovascular Age-Related Macular Degeneration Market Research

What is Neovascular Age-Related Macular Degeneration (nAMD)?

Neovascular age-related macular degeneration (nAMD, exudative, wet AMD) is a prevalent, progressive retinal degenerative macular disease that is characterized by neovascularization of the choroid, mainly affecting the elderly population, causing gradual vision impairment. Current therapeutic advancements slow the progression of the disease but do not cure or reverse its course. Newer therapies, including gene therapies, offer potential new targets for treatment.

Spherix Global Insights – Ophthalmology – Neovascular Age-Related Macular Degeneration (nAMD)

Spherix Global Insights’ Ophthalmology therapeutic team is a leading provider of independent syndicated Neovascular Age-Related Macular Degeneration market research, insights, business intelligence & advisory services.

Spherix’s studies publishing this year covering Neovascular Age-Related Macular Degeneration include:

  • RealTime Dynamix™: Neovascular Age-Related Macular Degeneration (US)
  • RealTime Dynamix™: Neovascular Age-Related Macular Degeneration (EU)
  • Launch Dynamix™: Eylea HD in Neovascular Age-Related Macular Degeneration (US)
  • Patient Chart Dynamix™: Neovascular Age-Related Macular Degeneration (US)

Spherix’s RealTime Dynamix™ service includes US quarterly deep dive reports and a Canadian semiannual report. Core content is supplemented with new variables each wave to provide both tracking of KPIs and an infusion of fresh market-driven insights.

Spherix’s Launch Dynamix™ service consists of two parts: monthly KPI tracking and quarterly deep dives. Monthly KPIs provide benchmarking of newly launched products for the first eighteen months of commercial availability, and quarterly deep dive reports includes promotional activity, barriers to uptake, and patient types gravitating to the launch brand.

Spherix’s Patient Chart Dynamix™ service includes patient-level data detailing clinical and non-clinical patient demographics, along with rationale for treatment choices. It reveals real patient management patterns through rigorous analysis of large-scale patient chart audits.

Follow us for ophthalmology industry news, insights & analysis:

https://www.linkedin.com/company/spherix-global-insights/

For Guests & Current Clients

For more details on Spherix’s primary market research reports and interactive dashboard offerings, visit or register here:

https://clientportal.spherixglobalinsights.com

 

Blaine Cloud
Franchise Leader, Ophthalmology
Email: [email protected]

HOW CAN WE PARTNER TOGETHER?

Get more information on Neovascular Age-Related Macular Degeneration Coverage